<DOC>
	<DOCNO>NCT01541553</DOCNO>
	<brief_summary>The purpose trial compare rate complete clearance actinic keratosis ( AK ) use sequential cryotherapy field treatment PEP005 Gel compare cryotherapy alone .</brief_summary>
	<brief_title>A Sequential Treatment Regimen Cryotherapy PicatoÂ® Treatment Actinic Keratosis Face Scalp</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Subjects must competent understand nature trial provide inform consent . Subjects 4 8 clinically typical , visible discrete AKs within contiguous 25 cm2 treatment area face scalp . Subject least 18 year age . Female subject must either : Nonchildbearing potential , i.e . postmenopausal confirm clinical history sterility ( e.g . subject without uterus ) , Childbearing potential , provide confirm negative urine pregnancy test prior study treatment , rule pregnancy . Female subject childbearing potential must willing use effective contraception . Location select treatment area : location face scalp within 5 cm incompletely heal wound within 10 cm suspect basal cell carcinoma ( BCC ) SCC Prior treatment PEP005 Gel face scalp . Selected treatment area lesion : atypical clinical appearance and/or recalcitrant disease History evidence skin condition trial indication would interfere evaluation trial medication Clinical diagnosis/history evidence medical condition would expose subject undue risk significant AE interfere assessment safety efficacy . Any abnormal vital sign measurement medically significant would impact safety subject interpretation trial result . Anticipated need hospitalization outpatient surgery first 15 day first trial medication application . Known sensitivity allergy ingredient PEP005 Gel Recent excessive exposure ultraviolet light Current enrolment participation clinical trial within 30 day entry study Subjects previously randomise trial Female subject breastfeed Prohibited Therapies and/or Medications within 2 week prior Visit 1 Cosmetic therapeutic procedure within 2 cm select treatment area Use acidcontaining therapeutic product within 2 cm select treatment area Use topical medicate cream , ointment , lotion , gel , foam spray Prohibited Therapies and/or Medications : within 4 week prior visit 1 : Treatment immunomodulators , cytotoxic drug interferon /interferon inducer Treatment systemic medication suppress immune system Treatment/therapy ultraviolet light A ( UVA ) ultraviolet light B ( UVB ) . Prohibited Therapies and/or Medications within 8 week prior visit 1 : Treatment 5FU , imiquimod , diclofenac sodium , photodynamic therapy : within 2 cm select treatment area . Prohibited Therapies and/or Medications within 6 month prior visit 1 Use systemic retinoids biologic / monoclonal antibody therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>